Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teng Jia

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cell Reports. Medicine|October 5, 2023
Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcomeLu-Ping Yang, Teng-Jia Jiang, Ming-Ming He, et al.
Cancer Communications (London, England)|September 11, 2020
Germline mutational profile of Chinese patients under 70 years old with colorectal cancerTeng-Jia Jiang, Fang Wang, Ying-Nan Wang, et al.
American Journal of Cancer Research|October 12, 2020
Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm studyFeng Wang, Tian-Shu Liu, Xiang-Lin Yuan, et al.
Nature Communications|April 29, 2022
Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancerQi Zhao, Feng Wang, Yan-Xing Chen, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cell Reports. Medicine|October 5, 2023
Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcomeLu-Ping Yang, Teng-Jia Jiang, Ming-Ming He, et al.
Cancer Communications (London, England)|September 11, 2020
Germline mutational profile of Chinese patients under 70 years old with colorectal cancerTeng-Jia Jiang, Fang Wang, Ying-Nan Wang, et al.
American Journal of Cancer Research|October 12, 2020
Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm studyFeng Wang, Tian-Shu Liu, Xiang-Lin Yuan, et al.
Nature Communications|April 29, 2022
Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancerQi Zhao, Feng Wang, Yan-Xing Chen, et al.
Pageof 3